Abstract: The majority of primary glaucoma has a chronic course and induces visual loss finally. However it’s a pity that there’s no perfect cure for glaucoma but to reduce intraocular pressure to prevent further visual field defects, among which administering eyedrops is the most common and safest choice and may often be a life-long treatment for a glaucoma patient. Long-term administering of eyedrops would induce some side effects, especially may result in ocular surface disorders and significantly decrease the treatment efficacy. Therefore, how to improve the health condition of ocular surface for a glaucoma patient is an important issue for anti-glaucoma therapy. This paper focuses on the harmfulness of long-term topical antiglaucomatous therapy and the pathogenesis of the ocular surface diseases in glaucoma patients, and how to improve the glaucoma patient’s health condition of ocular surface.

Key words: text-indent: 0px, display: inline !important, font: medium Simsun, white-space: normal, float: none, letter-spacing: normal, color: rgb(0,0,0), word-spacing: 0px, -webkit-text-stroke-width: 0px">glaucoma/medication, ocular surface, dry eye